Rovolution, a subsidiary of Neuromeka, has raised $1.4 million (2 billion KRW) in Pre-Series A funding led by Gyeongnam Venture Investment. The two-year-old company has earned market recognition for its growth potential, building project experience with major clients including HD Hyundai Robotics, NAVER Labs, LG Display, and Samsung Display based on its technical capabilities in industrial robots and manufacturing process automation.

Rovolution’s core competitiveness lies in its full-cycle robot value chain encompassing robot manufacturing, solution implementation, and overhaul (robot disassembly, precision inspection, and regeneration). Building on technical expertise accumulated in industrial robots and large-scale manufacturing process automation, the company plans to develop next-generation manufacturing equipment robots centered on high-precision, high-reliability systems and pursue phased commercialization. This strategy aims to expand the customer base across diverse manufacturing industries.

Rovolution is also building a robot manufacturing foundry (MaaS: Manufacturing as a Service) system through collaboration with parent company Neuromeka. The integrated structure provides everything from robot design to prototype production and mass manufacturing, with production bases currently operating in Changwon, Gyeongnam Province and Pohang, Gyeongbuk Province. The company is also reviewing plans to advance smart manufacturing infrastructure in preparation for future demand expansion.

Rovolution has internalized its production foundation by strategically securing personnel and facilities to strengthen robot manufacturing competitiveness. Based on this foundation, the company is expanding its product portfolio beyond the display industry to diverse sectors including automotive, logistics, and medical fields, with discussions ongoing regarding potential follow-on investment.

Gyeongnam Venture Investment stated: “Rovolution is a company that combines robot technology based on understanding of industry-specific domains, cost competitiveness, and robot manufacturing foundry capabilities. We expect this investment will positively contribute not only to Rovolution’s external growth but also to enhancing the overall corporate value of the Neuromeka Group.”

Jong-hoon Park, CEO of Rovolution, commented: “We have grown rapidly while having our robot manufacturing capabilities and supply capacity validated across various industrial sites. Through this investment, we will further strengthen our manufacturing system centered on the new Changwon facility and accelerate business performance with the goal of achieving break-even point (BEP) in 2026.”